Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04085510 · ClinicalTrials.gov registry record · NA
Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania
A NA study of Breast Cancer and Neoplasms, sponsored by Wendie Berg.
- Active
- Registry status
- NA
- Development phase
- 1,647
- Enrollment target
- 3
- Study locations
NCT04085510 is a NA study of Breast Cancer and Neoplasms that is active but no longer recruiting, run by Wendie Berg. The registered enrollment target is 1,647 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (41% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT04085510, a NA study of Breast Cancer and Neoplasms, is active but no longer recruiting, sponsored by Wendie Berg.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,647 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a prospective clinical trial that will examine if contrast-enhanced mammography substantially improves breast cancer detection compared to mammography with tomosynthesis, with minimal increase in false-positives, in women with a personal history of breast cancer.
Conditions Studied
Interventions
- DEVICE Contrast-enhanced mammogram
Study Locations (3)
Pennsylvania
- Magee Womancare Passavant Cranberry - Cranberry Township
- Magee Womancare Monroeville - Monroeville
- Magee Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,647 participants |
| Start Date | 2019-10-23 |
| Est. Completion | 2028-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04085510
The ClinicalTrials.gov registry entry for NCT04085510 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,647 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (41% lower). The listed sponsor is Wendie Berg, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Contrast-enhanced mammogram is the first listed.
NCT04085510 reports 3 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04085510 about?
NCT04085510 is a clinical study titled "Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania". This is a prospective clinical trial that will examine if contrast-enhanced mammography substantially improves breast cancer detection compared to mammography with tomosynthesis, with minimal increase in false-positives, in women with a personal history of breast cancer.
What is the current status of trial NCT04085510?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,647 participants. The study started on 2019-10-23. Estimated completion is 2028-12-30.
What conditions does trial NCT04085510 study?
This clinical trial studies the following conditions: Breast Cancer, Neoplasms, Breast Neoplasms, Breast Cancer Female.
What interventions are being tested in trial NCT04085510?
The interventions under investigation include: Contrast-enhanced mammogram (DEVICE).
Who is sponsoring clinical trial NCT04085510?
This trial is sponsored by Wendie Berg, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04085510 being conducted?
This trial has 3 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.